Le défi du traitement de l'hypertension chez les diabétiques de type 2.

Translated title of the contribution: The challenge to treat hypertensive patients with type 2 diabetes

Norman M Kaplan

Research output: Contribution to journal › Article

Abstract

A MAJOR PROBLEM: High blood pressure and type 2 diabetes is a increasingly frequent condition. Microalbuminuria is an independent risk factor of cardiovascular complications. THERAPEUTIC STRATEGY: Because of the risk of cardiovascular disease, a treatment designed to lower the blood pressure should also reduce the microalbuminuria. Indapamid SR is an excellent choice.

Original languageFrench
JournalPresse medicale (Paris, France : 1983)
Volume31 Spec No 2
StatePublished - Oct 2002

Fingerprint

Type 2 Diabetes Mellitus
Cardiovascular Diseases
Blood Pressure
Hypertension
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)
  • Internal Medicine

Cite this

Le défi du traitement de l'hypertension chez les diabétiques de type 2. / Kaplan, Norman M.

In: Presse medicale (Paris, France : 1983), Vol. 31 Spec No 2, 10.2002.

Research output: Contribution to journal › Article

Kaplan, NM 2002, 'Le défi du traitement de l'hypertension chez les diabétiques de type 2.', Presse medicale (Paris, France : 1983), vol. 31 Spec No 2.
Kaplan NM. Le défi du traitement de l'hypertension chez les diabétiques de type 2. Presse medicale (Paris, France : 1983). 2002 Oct;31 Spec No 2.
Kaplan, Norman M. / Le défi du traitement de l'hypertension chez les diabétiques de type 2. In: Presse medicale (Paris, France : 1983). 2002 ; Vol. 31 Spec No 2.
@article{15ba1d12615b4f26a31b7f27c665fa0c,
title = "Le d{\'e}fi du traitement de l'hypertension chez les diab{\'e}tiques de type 2.",
abstract = "A MAJOR PROBLEM: High blood pressure and type 2 diabetes is a increasingly frequent condition. Microalbuminuria is an independent risk factor of cardiovascular complications. THERAPEUTIC STRATEGY: Because of the risk of cardiovascular disease, a treatment designed to lower the blood pressure should also reduce the microalbuminuria. Indapamid SR is an excellent choice.",
author = "Kaplan, {Norman M}",
year = "2002",
month = "10",
language = "French",
volume = "31 Spec No 2",
journal = "Presse medicale (Paris, France : 1983)",
issn = "0755-4982",
publisher = "Elsevier Masson",

}

TY - JOUR

T1 - Le défi du traitement de l'hypertension chez les diabétiques de type 2.

AU - Kaplan, Norman M

PY - 2002/10

Y1 - 2002/10

N2 - A MAJOR PROBLEM: High blood pressure and type 2 diabetes is a increasingly frequent condition. Microalbuminuria is an independent risk factor of cardiovascular complications. THERAPEUTIC STRATEGY: Because of the risk of cardiovascular disease, a treatment designed to lower the blood pressure should also reduce the microalbuminuria. Indapamid SR is an excellent choice.

AB - A MAJOR PROBLEM: High blood pressure and type 2 diabetes is a increasingly frequent condition. Microalbuminuria is an independent risk factor of cardiovascular complications. THERAPEUTIC STRATEGY: Because of the risk of cardiovascular disease, a treatment designed to lower the blood pressure should also reduce the microalbuminuria. Indapamid SR is an excellent choice.

UR - http://www.scopus.com/inward/record.url?scp=0036780713&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036780713&partnerID=8YFLogxK

M3 - Article

VL - 31 Spec No 2

JO - Presse medicale (Paris, France : 1983)

JF - Presse medicale (Paris, France : 1983)

SN - 0755-4982

ER -

Access to Document